Key result
Non-Hispanic Black race linked to ~3.5-fold higher cardiovascular mortality vs Mexican American breast cancer patients.
Why the study?
Racial and ethnic differences in cardiovascular disease burden among women with breast cancer suggest certain populations may be at heightened risk of adverse cardiovascular outcomes.
Are there racial disparities in cardiovascular and all-cause mortality among women with breast cancer?
Observational (n=669)
Yes
Are there racial disparities in cardiovascular and all-cause mortality among women with breast cancer?
Hazard Ratio: 3.46 (95% CI 1.66–7.24)
Among U.S. women with breast cancer, Non-Hispanic Black women experience a significantly higher burden of cardiovascular-specific mortality, highlighting a need for targeted cardiovascular risk mitigation strategies in this demographic.
May warrant enhanced CV surveillance in Non-Hispanic Black women with breast cancer; leaves open generalizability and intervention targets.
Background Cardiovascular complications are an important and increasingly recognized concern among women with breast cancer. Racial and ethnic differences in cardiovascular disease burden suggest that certain populations may be at heightened risk of adverse cardiovascular outcomes. This study examined racial differences in cardiovascular outcomes and mortality among women with breast cancer using data from the National Health and Nutrition Examination Survey (NHANES). Methods We conducted a retrospective observational analysis of 669 women with self-reported breast cancer identified in NHANES and linked to the National Death Index. Participants were categorized by race and ethnicity as Non-Hispanic White, Non-Hispanic Black, Mexican American, Other Hispanic, or Other Race. Heart failure prevalence was evaluated as a clinically relevant cardiovascular outcome. Multivariable Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause and cardiovascular-specific mortality, adjusting for demographic, socioeconomic, and clinical factors. Kaplan–Meier survival curves and forest plots were generated to visualize differences across groups. Results Non-Hispanic Black women demonstrated the highest prevalence of cardiovascular disease, including heart failure (8.2%), compared with Non-Hispanic White (7.4%), Other Race (6.1%), Other Hispanic (2.2%), and Mexican American women (1.7%). Non-Hispanic Black women showed a trend toward poorer survival outcomes, with an elevated risk of all-cause mortality (HR 1.80; 95% CI: 0.96–3.36) compared with Mexican American women. After multivariable adjustment, this association persisted (HR 1.81; 95% CI: 0.96–3.41). Cardiovascular-specific mortality was higher among Non-Hispanic Black women, reaching statistical significance in the fully adjusted model (adjusted HR 3.46; 95% CI: 1.66–7.24). Conclusion Racial differences in cardiovascular outcomes and mortality were observed among women with breast cancer, with Non-Hispanic Black women experiencing a higher burden. These findings highlight the need for targeted, evidence-based strategies to address cardiovascular risk and improve equitable outcomes in this population.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2026) conducted an observational in Breast cancer (n=669). Non-Hispanic Black race vs. Mexican American race was evaluated on Cardiovascular-specific mortality (HR 3.46, 95% CI 1.66-7.24). Among US women with breast cancer, Non-Hispanic Black race was associated with a significantly higher risk of cardiovascular-specific mortality compared to Mexican American women (adjusted HR 3.46).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: